Replies to post #22755 on Amarin Corp Plc (AMRN)

[alternatepatel]

James Murphy, its tough time for all longs, I myself have been averaging down since 11$.

It was trading at $7.5 before BD for AdCom were released. So if it was clean followed by a successful AdCom voting, we could have seen >9$ easily.

But we had a hiccup, coz the FDA was stuck in our throat. Now the company is trying everything - formal appealing - knocking doors of fda at high level - lobbying - considering alternatives - to get us back on the track where we were heading prior to BD release.

And there are plenty of evidences which can ensure that FDA will have to correct their mistakes ASAP. (refer clinical scientist's SA article).

For a moment , imagine that you are the FDA reviewer who first came up with a BRIGHT idea of rejecting the drug based on 3 past studies only to find yourself in trouble coz investors and sponsor are hitting hard on your doors to get answers....you too find after DD that OMG, you have f'd it up. What else would you do other than accepting your mistakes and approving the drug ?

Evidence against FDA are easy to understand even for a layman, I too went through the original results of AimHigh, HSPThrive and ACCORD to see it myself and found that all that clinical scientist had to say was true.

Decision is yours. Again I would recommend you must to go through what Steven Ketchum said on 3Q CC and section IV of SA article...you can go one step ahead and verify the failed trial results (links available on SA article) to reassess the possibilities here.